Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.
Repository Usage Stats
Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention of obstetric-related VTE is complicated by the need to consider fetal, as well as maternal, wellbeing when making management decisions. Although absolute VTE rates in this population are low, obstetric-associated VTE is an important cause of maternal morbidity and mortality. This manuscript, initiated by the Anticoagulation Forum, provides practical clinical guidance on the prevention and treatment of obstetric-associated VTE based on existing guidelines and consensus expert opinion based on available literature where guidelines are lacking.
Deep vein thrombosis
Practice Guidelines as Topic
Pregnancy Complications, Cardiovascular
Published Version (Please cite this version)10.1007/s11239-015-1309-0
Publication InfoBates, SM; Middeldorp, S; Rodger, M; James, Andra Hohler; & Greer, I (2016). Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis, 41(1). pp. 92-128. 10.1007/s11239-015-1309-0. Retrieved from https://hdl.handle.net/10161/15529.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Professor of Obstetrics and Gynecology
I am an OB-GYN and a specialist in maternal-fetal medicine and high-risk obstetrics. My research and publications pertain mainly to the care of women with blood disorders (thrombosis and thrombophilia), bleeding disorders (including von Willebrand disease), platelet disorders (including ITP), and sickle cell disease.